Borderline personality disorder, antisocial personality disorder and risk-taking among heroin users: findings from the Australian Treatment Outcome Study (ATOS)

被引:84
|
作者
Darke, S
Williamson, A
Ross, J
Teesson, M
Lynskey, M
机构
[1] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia
[2] Washington Univ, Dept Psychiat, St Louis, MO 63130 USA
基金
英国医学研究理事会;
关键词
ASPD; BPD; heroin; harm;
D O I
10.1016/j.drugalcdep.2003.12.002
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aim: To determine the relationship between borderline personality disorder (BPD), antisocial personality disorder (ASPD) and harm among current heroin users. Design: Cross-sectional survey. Setting: Sydney, Australia. Participants: 615 current heroin users. Findings: Forty-six percent met criteria for BPD, 71% for ASPD, and 38% met criteria for both diagnoses. ASPD was related to attempted suicide, lifetime overdose, polydrug use, depression and overall psychological distress. BPD was also related to each of these risk domains, and to needle risk and recent suicide as well. When analysed separately, both BPD and ASPD thus appeared to predict harm. For the purposes of further analysis, the relationships between BPD, ASPD and harm, the sample was divided into four independent diagnostic groups: no diagnosis (ND, 21%), ASPD only (ASPD, 33%), BPD only (BPD, 7%), ASPD plus BPD (DUAL, 38%). The division of the sample into four distinct diagnostic groups produced substantially different results. There were strong relationships between BPD and attempted suicide, needle sharing and psychopathology. In none of these domains did the ASPD group significantly differ from the ND group. Also, the levels of harm among the DUAL group were identical to BPD, suggesting no additive risk from ASPD. Thus, while initial analyses suggested an increased risk for ASPD patients for suicide and psychopathology, these relationships disappeared after BPD was taken into account. The only domain in which there appeared to be an additive risk for ASPD and BPD, was heroin overdose. Conclusions: The extensive comorbidity between BPD and ASPD means that, unless BPD is controlled for, artefactual relationships may emerge between ASPD and harm. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:77 / 83
页数:7
相关论文
共 50 条
  • [1] Altered psychophysiological correlates of risk-taking in borderline personality disorder
    Huepen, Philippa
    Wagels, Lisa
    Weidler, Carmen
    Kable, Joseph W.
    Schneider, Frank
    Habel, Ute
    PSYCHOPHYSIOLOGY, 2020, 57 (05)
  • [2] Borderline personality disorder: The concept of risk-taking in clinical practice
    Krawitz, R
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2000, 34 : A39 - A40
  • [3] The characteristics of heroin users entering treatment: findings from the Australian Treatment Outcome Study (ATOS)
    Ross, J
    Teesson, M
    Darke, S
    Lynskey, M
    Ali, R
    Ritter, A
    Cooke, R
    DRUG AND ALCOHOL REVIEW, 2005, 24 (05) : 411 - 418
  • [4] Oxcarbazepine in the treatment of severe borderline and antisocial personality disorder
    Mikirditsian, O.
    Istikoglou, C.
    Michelidakis, K.
    Vlissides, D.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 202 - 202
  • [5] Impulsivity and Risk-Taking in Borderline Personality Disorder With and Without Substance Use Disorders
    Coffey, Scott F.
    Schumacher, Julie A.
    Baschnagel, Joseph S.
    Hawk, Larry W.
    Holloman, Garland
    PERSONALITY DISORDERS-THEORY RESEARCH AND TREATMENT, 2011, 2 (02) : 128 - 141
  • [6] Do people with borderline personality disorder complicated by antisocial personality disorder benefit from the STEPPS treatment program?
    Black, Donald W.
    Simsek-Duran, Fatma
    Blum, Nancee
    McCormick, Brett
    Allen, Jeff
    Personality and Mental Health, 2016, 10 (03) : 205 - 215
  • [7] Health service utilization and benzodiazepine use among heroin users: findings from the Australian Treatment Outcome Study (ATOS)
    Darke, S
    Ross, J
    Teesson, M
    Lynskey, M
    ADDICTION, 2003, 98 (08) : 1129 - 1135
  • [8] A prospective, longitudinal, study of men with borderline personality disorder with and without comorbid antisocial personality disorder
    Robitaille, Marie-Pier
    Checknita, Dave
    Vitaro, Frank
    Tremblay, Richard E.
    Paris, Joel
    Hodgins, Sheilagh
    BORDERLINE PERSONALITY DISORDER AND EMOTION DYSREGULATION, 2017, 4
  • [9] A prospective, longitudinal, study of men with borderline personality disorder with and without comorbid antisocial personality disorder
    Marie-Pier Robitaille
    Dave Checknita
    Frank Vitaro
    Richard E. Tremblay
    Joel Paris
    Sheilagh Hodgins
    Borderline Personality Disorder and Emotion Dysregulation, 4
  • [10] Risperidone treatment of borderline personality disorder assessed by a borderline personality disorder-specific outcome measure - A pilot study
    Friedel, Robert O.
    Jackson, Warren T.
    Huston, Celia S.
    May, Roberta S.
    Kirby, Nancy L.
    Stoves, Andre
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (03) : 345 - 347